Accepted for Publication: May 28, 2013.
Published Online: August 12, 2013. doi:10.1001/jamainternmed.2013.9051.
Study concept and design: Dunkler, Dehghan, Heinze, Clase, Mann, Yusuf, Oberbauer.
Acquisition of data: Dehghan, Teo, Mann.
Analysis and interpretation of data: Dunkler, Dehghan, Heinze, Gao, Kohl, Clase, Mann, Yusuf, Oberbauer.
Drafting of the manuscript: Dunkler, Dehghan, Gao, Oberbauer.
Critical revision of the manuscript for important intellectual content: Dunkler, Dehghan, Teo, Heinze, Kohl, Clase, Mann, Yusuf, Oberbauer.
Statistical analysis: Dunkler, Dehghan, Heinze, Gao, Kohl, Oberbauer.
Obtained funding: Mann, Yusuf, Oberbauer.
Administrative, technical, and material support: Teo, Mann.
Study supervision: Heinze, Mann, Oberbauer.
Conflict of Interest Disclosures: None reported.
Funding/Support: The ONTARGET trial was sponsored by Boehringer-Ingelheim. The observational study presented herein was funded by SysKid, a collaborative FP7 research project to fight CKD (grant HEALTH-F2-2009-241544).
Role of the Sponsors: The study sponsor had no role in study design, analysis, or interpretation of data.